- CEO
- Takashi Okura
- Full Time Employees
- 1,354
- Sector
- Consumer non-durables
- Industry
- Household/Personal care
- Address
- 6-13-1 Minatojima-Nakamachi Kobe Japan 650-8521
- IPO Date
- Mar 22, 2011
- Business
- Noevir Holdings Co., Ltd. develops, manufactures and sells cosmetics, pharmaceuticals, health foods, toiletries and related products primarily in Japan with operations extending to China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States and Canada. The company's Cosmetics segment offers high-performance functional prestige skincare under the Noevir brand through face-to-face channels such as beauty salons and Group online stores; self-selection cosmetics including the Namerakahonpo skincare line, excel makeup line and NOV hypoallergenic cosmetics sold via general retailers and Group online stores; and contract manufacturing services for cosmetics and quasi-drugs on an OEM basis. The Pharmaceuticals & Health Food segment produces and markets flagship items such as Nanten Nodo Ame cough drops, functional drinks in the Min Min Da Ha lineup, over-the-counter pharmaceuticals comprising cold remedies, eye drops and digestive aids, nutritional supplements with high-quality natural ingredients and health food products including tea, distributed through drug stores, variety stores, dermatology and medical institutions as well as Noevir beauty studios and own retail stores. The Other segment engages in apparel sales, aircraft and vessel purchase/sale, aviation-related operations including air transportation and pilot training via subsidiary Noevir Aviation Co., Ltd., and leasing activities. Founded in 1964 as Noevir Co., Ltd. and established as the current holding company in 2011, Noevir Holdings is headquartered in Kobe, Japan, and listed on the Tokyo Stock Exchange Prime Market (ticker: 4928); it maintains 13 consolidated subsidiaries with 1,369 employees as of September 30, 2024. In fiscal 2025 ended September 30, 2025, the company achieved record-high net income attributable to owners of the parent at ¥8,030 million on net sales of ¥64,724 million (up 1.4% year-on-year), reflecting modest growth in the Cosmetics segment (¥50,525 million sales, up 1.5%) driven by innovation in domestic markets and brand enhancement efforts; it continues pursuing its medium- to long-term strategy of realizing steady growth through sustainability across segments, including human resource diversification, R&D/production/logistics system strengthening and adaptive management amid uncertain economic conditions with rising prices impacting consumer spending.